US Stock MarketDetailed Quotes

IMNN Imunon

Watchlist
  • 0.8775
  • -0.0187-2.08%
Close Apr 25 16:00 ET
  • 0.9366
  • +0.0591+6.73%
Pre 08:00 ET
12.83MMarket Cap-0.54P/E (TTM)

About Imunon Company

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Company Profile

SymbolIMNN
Company NameImunon
Listing DateFeb 8, 2008
Founded1982
CEODr. Stacy R. Lindborg, PhD
MarketNASDAQ
Employees33
Fiscal Year Ends12-31
Address997 Lenox Drive,Suite 100
CityLawrenceville
ProvinceNew Jersey
CountryUnited States of America
Zip Code08648
Phone1-609-896-9100

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Stacy R. Lindborg, PhD
  • Director, President and Chief Executive Officer
  • 44.10K
  • Dr. Douglas Faller, M.D.
  • Chief Medical Officer
  • --
  • David Gaiero
  • Chief Financial Officer and Chief Accounting Officer
  • --
  • Dr. Khursheed Anwer, M.B.A.,PhD
  • Executive Vice President and Chief Scientific Officer
  • 680.16K
  • Michael H. Tardugno
  • Executive Chairman of the Board
  • --
  • Christine A. Pellizzari
  • Independent Director
  • 47.70K
  • James E. Dentzer
  • Independent Director
  • 61.20K
  • Frederick J. Fritz
  • Independent Director
  • 106.20K
  • Dr. Donald Braun, PhD
  • Independent Director
  • 72.90K
  • Susan Eylward
  • General Counsel and Corporate Secretary
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More